Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun 25;2(6):e256.
doi: 10.1371/journal.pntd.0000256.

Neglected infections of poverty in the United States of America

Affiliations

Neglected infections of poverty in the United States of America

Peter J Hotez. PLoS Negl Trop Dis. .

Abstract

In the United States, there is a largely hidden burden of diseases caused by a group of chronic and debilitating parasitic, bacterial, and congenital infections known as the neglected infections of poverty. Like their neglected tropical disease counterparts in developing countries, the neglected infections of poverty in the US disproportionately affect impoverished and under-represented minority populations. The major neglected infections include the helminth infections, toxocariasis, strongyloidiasis, ascariasis, and cysticercosis; the intestinal protozoan infection trichomoniasis; some zoonotic bacterial infections, including leptospirosis; the vector-borne infections Chagas disease, leishmaniasis, trench fever, and dengue fever; and the congenital infections cytomegalovirus (CMV), toxoplasmosis, and syphilis. These diseases occur predominantly in people of color living in the Mississippi Delta and elsewhere in the American South, in disadvantaged urban areas, and in the US-Mexico borderlands, as well as in certain immigrant populations and disadvantaged white populations living in Appalachia. Preliminary disease burden estimates of the neglected infections of poverty indicate that tens of thousands, or in some cases, hundreds of thousands of poor Americans harbor these chronic infections, which represent some of the greatest health disparities in the United States. Specific policy recommendations include active surveillance (including newborn screening) to ascertain accurate population-based estimates of disease burden; epidemiological studies to determine the extent of autochthonous transmission of Chagas disease and other infections; mass or targeted treatments; vector control; and research and development for new control tools including improved diagnostics and accelerated development of a vaccine to prevent congenital CMV infection and congenital toxoplasmosis.

PubMed Disclaimer

Conflict of interest statement

PJH is Executive Director of the Global Network for Neglected Tropical Disease Control (GNNTDC), the Director of the Human Hookworm Vaccine Initiative (HHVI), and President of the Sabin Vaccine Institute. He is an inventor on an international patent for a hookworm vaccine. The author recused himself from all editorial decisions regarding this paper.

Figures

Figure 1
Figure 1. Location of Counties That Represent Spatial Clusters in Which Poverty Rates Are at Least Two Standard Deviations Higher Than the National Mean.
Top: Counties south of the Continental Divide. Bottom: Counties north of the Continental Divide. From Holt .

References

    1. Armstrong GL, Conn LA, Pinner RW. Trends in infectious disease mortality in the United States during the 20th century. JAMA. 1999;281:61–66. - PubMed
    1. Humphreys M. Malaria: Poverty, Race, and Public Health in the United States. Baltimore and London: Johns Hopkins University Press; 2001. pp. 49–68.
    1. Hotez PJ. Neglected diseases and poverty in “The Other America”: The greatest health disparity in the United States? PLoS Negl Trop Dis. 2007;1:e159. doi:10.1371/journal.pntd.0000149. - PMC - PubMed
    1. Hotez PJ, Molyneux DH, Fenwick A, Kumaresan J, Ehrlich Sachs S, et al. Control of neglected tropical diseases. N Engl J Med. 2007;357:1018–27. - PubMed
    1. Hotez PJ, Ferris MT. The antipoverty vaccines. Vaccine. 2006;24:5787–99. - PubMed